EMA: ‘global, monopoly, outsourcing cause meds shortages’, industry must de-risk
This article was originally published in Scrip
Executive Summary
The European Medicines Agency wants to up the pressure on pharmaceutical companies so that they are more "proactive" about managing manufacturing-related risks that can disrupt the supply of medicines.